The global CAR T-cell therapy market has read more witnessed significant development in recent years. This movement is driven by the increasing prevalence of cancer, advancements in therapy, and a surging demand for successful treatment options. The market is anticipated to attain a value of hundreds of billions of dollars by the end of the decade,